Figure 4.

SROC curve for positive immunocytochemistry expression of CK-19, Gal-3 and HBME-1 in the diagnosis of well-differentiated malignant lesions of the thyroid. Areas under the SROC curve: CK-19=86.32%; Gal-3=97.07%; HBME-1=94.12%.

de Matos et al. Diagnostic Pathology 2012 7:97   doi:10.1186/1746-1596-7-97
Download authors' original image